NVLIX
Price
$61.97
Change
-$0.20 (-0.32%)
Updated
Jun 18 closing price
Net Assets
853.65M
RGACX
Price
$75.73
Change
+$0.02 (+0.03%)
Updated
Jun 18 closing price
Net Assets
306.93B
Interact to see
Advertisement

NVLIX vs RGACX

Header iconNVLIX vs RGACX Comparison
Open Charts NVLIX vs RGACXBanner chart's image
Nuveen Winslow Large-Cap Growth ESG I
Price$61.97
Change-$0.20 (-0.32%)
VolumeN/A
Net Assets853.65M
American Funds Growth Fund of Amer R3
Price$75.73
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets306.93B
NVLIX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NVLIX vs. RGACX commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVLIX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 307B vs. NVLIX (854M). RGACX pays higher dividends than NVLIX: RGACX (0.08) vs NVLIX (0.00). NVLIX was incepted earlier than RGACX: NVLIX (16 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than NVLIX (0.83). NVLIX is a more actively managed with annual turnover of: 56.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than NVLIX: RGACX (250) vs NVLIX (100000). RGACX annual gain was more profitable for investors over the last year : 5.98 vs. NVLIX (-5.59). RGACX return over 5 years is better than : 42.39 vs. NVLIX (36.35).
NVLIXRGACXNVLIX / RGACX
Total Expense Ratio0.650.9469%
Annual Report Gross Expense Ratio0.830.9488%
Fund Existence16 years23 years-
Gain YTD2.3455.19545%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets854M307B0%
Annual Yield % from dividends0.000.08-
Returns for 1 year-5.595.98-93%
Returns for 3 years51.2254.4694%
Returns for 5 years36.3542.3986%
Returns for 10 years33.1568.8348%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPST6.900.05
+0.73%
Tempest Therapeutics Inc
ANGO10.230.07
+0.69%
AngioDynamics
BCSF14.980.10
+0.67%
Bain Capital Specialty Finance
DD66.86-0.28
-0.42%
DuPont de Nemours
PRIM74.64-0.38
-0.51%
Primoris Services Corp